Related Experiment Videos
Pyruvate in organ transplantation
1Division of Transplantation Surgery, University of Illinois at Chicago, 60612, USA. cicalese@uic.edu
JPEN. Journal of Parenteral and Enteral Nutrition
|July 4, 2001
Summary
Pyruvate (PY) protects organs from damage during transplantation and preservation. Supplementation with PY enhances cell viability during hypoxia and reduces rejection, suggesting its potential as a beneficial nutrient in organ transplantation.
Area of Science:
- Biochemistry
- Immunology
- Transplantation Science
Background:
- Pyruvate (PY) is a key energetic substrate for cells during anaerobic conditions.
- Previous studies demonstrated PY's protective effects against ischemia/reperfusion injury in various organs.
Purpose of the Study:
- To evaluate the efficacy of pyruvate in organ preservation and transplantation.
- To investigate PY's role in mitigating organ injury and rejection.
Main Methods:
- Experimental models of organ ischemia/reperfusion injury.
- Assessment of organ preservation using PY-based solutions.
- In vivo studies of oral PY treatment in allograft rejection.
- In vitro culture of pancreatic islets in PY-enriched media.
Main Results:
- PY demonstrated protective effects on intestinal preservation and reduced acute rejection.
- Oral PY treatment modulated immune responses in rejecting allografts, inhibiting key inflammatory markers.
- PY-based preservation solutions improved liver preservation.
- Pancreatic islets cultured in PY-enriched media maintained viability and function for extended periods.
Conclusions:
- Pyruvate shows significant potential as a protective agent in organ transplantation and preservation.
- PY may enhance cell survival during hypoxia and modulate immune responses, reducing allograft rejection.
- Further clinical investigation of pyruvate for organ transplantation is warranted.